Evidence-Based Medicine Guidelines
Monoamine oxidase inhibitors (MAOIs) for fibromyalgia syndrome
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Monoamine Oxidase Inhibitors (MAOIs) for Fibromyalgia Syndrome." Evidence-Based Medicine Guidelines, Duodecim Medical Publications Limited, 2019. Evidence Central, evidence.unboundmedicine.com/evidence/view/EBMG/457576/all/Monoamine_oxidase_inhibitors__MAOIs__for_fibromyalgia_syndrome.
Monoamine oxidase inhibitors (MAOIs) for fibromyalgia syndrome. Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. https://evidence.unboundmedicine.com/evidence/view/EBMG/457576/all/Monoamine_oxidase_inhibitors__MAOIs__for_fibromyalgia_syndrome. Accessed September 23, 2023.
Monoamine oxidase inhibitors (MAOIs) for fibromyalgia syndrome. (2019). In Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited. https://evidence.unboundmedicine.com/evidence/view/EBMG/457576/all/Monoamine_oxidase_inhibitors__MAOIs__for_fibromyalgia_syndrome
Monoamine Oxidase Inhibitors (MAOIs) for Fibromyalgia Syndrome [Internet]. In: Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. [cited 2023 September 23]. Available from: https://evidence.unboundmedicine.com/evidence/view/EBMG/457576/all/Monoamine_oxidase_inhibitors__MAOIs__for_fibromyalgia_syndrome.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Monoamine oxidase inhibitors (MAOIs) for fibromyalgia syndrome
ID - 457576
BT - Evidence-Based Medicine Guidelines
UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/457576/all/Monoamine_oxidase_inhibitors__MAOIs__for_fibromyalgia_syndrome
PB - Duodecim Medical Publications Limited
DB - Evidence Central
DP - Unbound Medicine
ER -
